The affected products include blood oxygenators, reservoirs, pumps, cannulae and tubing packs.
The recall was initiated after a limited number of lots of Carmeda-coated products, manufactured with heparin, were found to have been contaminated with oversulfated chondroitin sulfate. The patient risk associated with the presence of the sulfate in heparin-coated medical devices is unknown at this time, but the FDA has received reports of serious injury and death in patients who administered injectable heparin products containing high levels of the sulfate.
Read more about the voluntary Medtronic recall.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
